"To really make breast cancer a treatable disease, we have to be able to find a way to prevent or reduce the amount of metastasis," Otey said.
"Now that we see palladin is expressed mostly in invasive cells, it raises the question as to whether it might be useful as a prognostic marker.
"Maybe someday doctors could test for the presence of palladin to identify patients who have the most aggressive tumours, then give those patients personalized, more aggressive treatment," Otey added.
The study appeared in the Nov. 3, 2008, online edition of the journal Oncogene.
Source-ANI
SK